FOLH1 and prostate carcinoma: Finally, in prostate cancer (PCa), 99mTc-labeled iron oxide nanoparticles functionalized with prostate-specific membrane antigen (PSMA) and BBN showed high in vitro stability and enhanced affinity and specificity for PSMA- and GRPR-positive PCa cells.